drugset / Trial / NCT01901185
Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the ability of people with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) to use an experimental autoinjector to self inject etanercept (Enbrel®).
Timeline
- Start
- 2013-06-11
- Primary completion
- 2013-12-18
- Completion
- 2013-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Etanercept | Protein / enzyme biologic | 50 mg | Subcutaneous |